These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1161056)
41. Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Haeusler G Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):07-111. PubMed ID: 4281069 [No Abstract] [Full Text] [Related]
42. Adrenoreceptors in the cardiovascular system of the domestic fowl. Bolton TB; Bowman WC Eur J Pharmacol; 1969 Jan; 5(2):121-32. PubMed ID: 4388696 [No Abstract] [Full Text] [Related]
43. Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Feniuk W; Humphrey PP; Watts AD Br J Pharmacol; 1979 Oct; 67(2):247-54. PubMed ID: 497528 [TBL] [Abstract][Full Text] [Related]
44. A comparative study of the role played by some inactivation pathways in the disposition of the transmitter in the rabbit aorta and the saphenous vein of the dog. Brandão F Blood Vessels; 1976; 13(5):309-18. PubMed ID: 974271 [TBL] [Abstract][Full Text] [Related]
45. Studies of DMAE-induced potentiation of the pressor and contractile responses to exogenous norepinephrine in normal and reserpine treated animals. Greenberg S; Long JP Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):365-75. PubMed ID: 5089224 [No Abstract] [Full Text] [Related]
46. Analysis of the beta-receptor mediated effect on slow-contracting skeletal muscle in vitro. Waldeck B J Pharm Pharmacol; 1977 Sep; 29(9):550-4. PubMed ID: 21260 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs. Ambache N; Dunk LP; Verney J; Zar MA J Physiol; 1972 Dec; 227(2):433-56. PubMed ID: 4345926 [TBL] [Abstract][Full Text] [Related]
48. Prejunctional effects of a purified toxin from the scorpion Tityus serrulatus: release of 3H-noradrenaline and enhancement of transmitter overflow elicited by nerve stimulation. Langer SZ; Adler-Graschinsky E; Almeida AP; Diniz CR Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(3):243-59. PubMed ID: 1153019 [TBL] [Abstract][Full Text] [Related]
49. Effects of oxyfedrine on isolated portal vein and other smooth muscles. Mackenzie JE; Parratt JR Br J Pharmacol; 1973 Apr; 47(4):827-37. PubMed ID: 4146743 [TBL] [Abstract][Full Text] [Related]
50. STUDIES ON SYMPATHOMIMETIC ACTION OF ACETALDEHYDE. I. EXPERIMENTS WITH BLOOD PRESSURE AND NICTITATING MEMBRANE RESPONSES. AKABANE J; NAKANISHI S; KOHEI H; MATSUMURA R; OGATA H Jpn J Pharmacol; 1964 Sep; 14():295-307. PubMed ID: 14265196 [No Abstract] [Full Text] [Related]
51. The effect of isoprenaline on adrenoceptors in human saphenous vein. Coupar IM Br J Pharmacol; 1970 Jul; 39(3):465-75. PubMed ID: 4394337 [TBL] [Abstract][Full Text] [Related]
52. On the mechanism of action of amezinium methylsulphate on the dog saphenous vein. Araújo D; Caramona MM; Osswald W Eur J Pharmacol; 1983 Jun; 90(2-3):203-14. PubMed ID: 6873182 [TBL] [Abstract][Full Text] [Related]
53. Effect of nitroprusside on smooth muscle and adrenergic nerve terminals in isolated blood vessels. Verhaeghe RH; Shepherd JT J Pharmacol Exp Ther; 1976 Oct; 199(1):269-77. PubMed ID: 978482 [TBL] [Abstract][Full Text] [Related]
54. Motor innervation of the smooth muscle of the rat seminal vesicle. Fedan JS; Besse JC; Carpenter FG; Teague RS J Pharmacol Exp Ther; 1977 May; 201(2):285-97. PubMed ID: 16117 [TBL] [Abstract][Full Text] [Related]
55. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids. Stürmer E Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143 [TBL] [Abstract][Full Text] [Related]
57. The effects of perhexiline on the sympathetic nervous system. Daniell HB; Saelens DA; Webb JG J Pharmacol Exp Ther; 1979 May; 209(2):292-6. PubMed ID: 439004 [TBL] [Abstract][Full Text] [Related]
58. THE RESPONSES TO TYRAMINE OF THE NORMAL AND DENERVATED NICTITATING MEMBRANE OF THE CAT: ANALYSIS OF THE MECHANISMS AND SITES OF ACTION. HAEFELY W; HUERLIMANN A; THOENEN H Br J Pharmacol Chemother; 1963 Aug; 21(1):27-38. PubMed ID: 14066148 [TBL] [Abstract][Full Text] [Related]
59. A study of the conformational requirements for direct adrenergic stimulation. Gray AP; Reit E; Ackerly JA; Hava M J Med Chem; 1973 Sep; 16(9):1023-7. PubMed ID: 4147657 [No Abstract] [Full Text] [Related]